Titration Pressures in Sleep Apnea Patients Using ThermoSmart® Versus Conventional Humidification

This study has been completed.
Sponsor:
Collaborator:
Sleep Disorder Centers Institute for Clinical Research
Information provided by:
Fisher and Paykel Healthcare
ClinicalTrials.gov Identifier:
NCT00681083
First received: May 19, 2008
Last updated: July 10, 2011
Last verified: July 2011

May 19, 2008
July 10, 2011
April 2008
July 2008   (final data collection date for primary outcome measure)
Titration pressures after treatment nights [ Time Frame: End of titration night ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00681083 on ClinicalTrials.gov Archive Site
Sleep Quality based on objective measures of sleep architecture and EEG arousals [ Time Frame: End of titration night ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Titration Pressures in Sleep Apnea Patients Using ThermoSmart® Versus Conventional Humidification
Titrations Pressures in Sleep Apnea Patients Using ThermoSmart® Versus Conventional Humidification

Patients who have Obstructive Sleep Apnea (OSA) may have different Continuous Positive Airway Pressure (CPAP)when titrated with different levels of humidification. It is hypothesised that patients with ThermoSmart® technology (heated breathing tube technology) will have lower titrated pressures than those who are titrated using conventional humidification (non heated breathing tube).

Debate is present concerning the optimal level of humidification for obstructive sleep apnea (OSA) patients who need continuous positive airway pressure (CPAP) therapy. Recent evidence has shown that using a heated breathing tube to increase the amount of humidification that can be delivered has decreased patient side effects, increased subjective sleep quality and decreased subjective symptom scores. Anecdotal evidence exists, in the form of clinical observation, when ThermoSmart® technology is utilized during CPAP titration, patients laboratory titrated pressure may in fact prove to be lower. The possibility exists, on a titration night, patients potentially may experience an adverse response to the positive airway pressure which manifests as increased airway resistance and inflammation necessitating higher CPAP pressures to overcome upper airway resistance and flow limitation. Therefore, we hypothesize the delivery of higher levels of humidity might reduce the nasal airway resistance during the titration night, reducing the overall positive airway pressure requirements. The goal is to investigate this phenomenon to find if a reduction in pressure is necessary and if so to what degree. Patients who are titrated on Continuous Positive Airway Pressure devices with ThermoSmart® technology will have lower titrated pressures than those who are titrated using conventional humidification.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Treatment
Sleep Apnea, Obstructive
  • Device: Heated breathing tube (CPAP with ThermoSmart)
    CPAP with ThermoSmart - heated passover humidifier, with heated breathing tube
    Other Name: ThermoSmart
  • Device: Non heated breathing tube (CPAP with conventional humidification)
    CPAP with conventional humidification - heated passover humidifier, no heated breathing tube
    Other Name: Conventional humidification
  • Experimental: 1
    Heated breathing tube
    Intervention: Device: Heated breathing tube (CPAP with ThermoSmart)
  • Active Comparator: 2
    Non heated breathing tube
    Intervention: Device: Non heated breathing tube (CPAP with conventional humidification)
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
20
July 2008
July 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Male and Female patients over the age of 18
  • Apnea Hypopnea Index (AHI) ≥15
  • Patients must have at least 5 hours sleep time on each titration night
  • Stable medications for 2 weeks prior to entry to the study and for study inclusion duration including sleep aids

Exclusion Criteria:

  • Receiving or requiring bi-level ventilation
  • Use of a full face interface or chin strap
  • Previous UPPP surgery or palatal reconstruction
  • Recent angina symptoms within 2 weeks of entry
  • CHF with EF < 40%
  • Obesity Hypoventilation Syndrome
  • Cheyne Stokes respiration
  • > 50% Central apneas recorded on diagnostic polysomnogram
  • Supplemental oxygen use
  • Use of narcotic pain medication
  • Hypoxemia as determined by room air pulse oxymetry of less than 89% on room air at rest awake
  • Inability to tolerate positive pressure therapy
  • Split Night Evaluations
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00681083
FPHC SDC 2008
No
Emma Duckworth/Clinical Research Manager, Fisher & Paykel Healthcare
Fisher and Paykel Healthcare
Sleep Disorder Centers Institute for Clinical Research
Principal Investigator: Kevin L Lewis, M.D. Sleep Disorder Centers Institute for Clinical Research
Fisher and Paykel Healthcare
July 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP